首页> 外文OA文献 >Immune checkpoint proteins CTLA-4, PD-1 and PD-L1 in melanoma as predictive biomarkers to guide clinical decisions

【2h】

Immune checkpoint proteins CTLA-4, PD-1 and PD-L1 in melanoma as predictive biomarkers to guide clinical decisions

机译：免疫检查点蛋白CTLA-4，PD-1和PD-L1在黑色素瘤中作为预测生物标志物引导临床决策

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Markus Tiemann; Vera Samoilova; Dmitri Atiakshin; Igor Buchwalow;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade [J] . Oleg Milberg, Chang Gong, Mohammad Jafarnejad, Scientific reports. . 2019,第1期

机译：用于预测CTLA-4，PD-1和PD-L1 Checkpoint封锁CTLA-4，PD-1和PD-L1 Checkpoint封锁对单一疗法，组合和顺序治疗的临床反应的QSP模型
2. Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer [J] . Shien Kazuhiko, Papadimitrakopoulou Vassiliki A., Wistuba Ignacio I. Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Null期

机译：非小细胞肺癌对PD-1 / PD-L1免疫检查点抑制剂反应的预测生物标志物
3. Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer [J] . Shien Kazuhiko, Papadimitrakopoulou Vassiliki A., Wistuba Ignacio I. Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Null期

机译：非小细胞肺癌PD-1 / PD-L1免疫检查点抑制剂的预测生物标志物
4. Who Bridged the "Valley of Death" Between Basic Research and Clinical Research? In the Case of Immune-Checkpoints CTLA-4 and PD-1 Based on Inter-Citation Network [C] . Qiuju Zhou, Guilin Meng, Ying Ding Annual Meeting of the Association for Information Science and Technology . 2019

机译：谁在基础研究和临床研究之间桥梁“死亡”？在基于引文中的免疫检查点CTLA-4和PD-1的情况下
5. Overcoming Melanoma Immune Tolerance: Non-specific CTLA-4 Blockade/Interferon-alpha and Antigen Specific Immunization with TLR-9 Stimulation/Local GM-CSF as Components of a Melanoma Immunotherapeutic Strategy and Associated Biomarkers of Therapeutic Benefit. [D] . Tarhini, Ahmad A. 2011

机译：克服黑色素瘤的免疫耐受性：非特异性CTLA-4阻断/干扰素-α和抗原特异性免疫，TLR-9刺激/局部GM-CSF作为黑色素瘤免疫治疗策略的组成部分和相关的治疗有益生物标志物。
6. Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers [O] . João Lobo, Ângelo Rodrigues, Rita Guimarães, 2019

机译：睾丸生殖细胞肿瘤中免疫细胞浸润的详细表征以及免疫检查点分子PD-L1 / CTLA-4和MMR蛋白的表达揭示了新的疾病生物标记
7. Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers [O] . João Lobo, Ângelo Rodrigues, Rita Guimarães, 2019

机译：微细胞浸润的详细表征免疫细胞浸润和免疫检查点分子PD-L1 / CTLA-4和MMR蛋白在睾丸生殖细胞瘤中的表达揭示了新型疾病生物标志物

Immune checkpoint proteins CTLA-4, PD-1 and PD-L1 in melanoma as predictive biomarkers to guide clinical decisions

著录项

引文网络

相似文献

相关主题

期刊订阅